The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Stimulant-Induced Enhanced Sexual Desire as a Potential Contributing Factor in HIV Transmission
Abstract
OBJECTIVE: Stimulant abuse is associated with an increased risk of contracting human immunodeficiency virus (HIV). Although sharing of contaminated needles is one of the routes by which HIV is spread, noninjection abusers are also at high risk. The authors investigated the effect of the stimulant drug methylphenidate (given intravenously) on sexual desire as a possible contributing factor to risky sexual behavior associated with the contraction of HIV. METHOD: The effects of intravenous methylphenidate (0.5 mg/kg) on self-reports of sexual desire (rated from 0-10) were evaluated in 39 comparison subjects and 39 cocaine abusers. RESULTS: Intravenous methylphenidate significantly increased self-reports of sexual desire in comparison subjects (1.4 versus 3.7) and cocaine abusers (2.8 versus 4.8). CONCLUSIONS: Stimulant-induced enhancement of sexual desire could be one mechanism by which stimulant drugs such as cocaine and methamphetamine increase the risk for HIV transmission even when they are not injected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are associated with increased risk-taking and delay discounting (Berry et al., 2022;Skryabin et al., 2020;Volkow et al., 2007).”
From A motivation model of sex addiction – Relevance to the controversy over the concept (2022) · cites this paper as Volkow et al., 2007
Citations
Cites
Leigh, B., & Stall, R. (1993) · American Psychologist · doi:10.1037//0003-066x.48.10.1035 · Cited by 720
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
Leigh, B. C., & Stall, R. (1993) · American Psychologist · doi:10.1037/0003-066x.48.10.1035 · Cited by 589
Volkow, N. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180042006 · Cited by 575
Self-citationMelis, M. R., & Argiolas, A. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00020-2 · Cited by 428
Rosenkranz, J. A., & Grace, A. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-11-04090.2001 · Cited by 339
(1998) · Europe PMC (PubMed Central) · Cited by 336
Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281
Self-citationColfax, G. N. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti025 · Cited by 265
Hypersexuality with Antiparkinsonian Therapy
Uitti, R. J., Tanner, C. M., Rajput, A. H., Goetz, C. G., Klawans, H. L., & Thiessen, B. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198910000-00002 · Cited by 213
Volkow, N. D., Wang, G., Fowler, J. S., Fischman, M. W., Foltin, R. W., Abumrad, N. N., Gatley, S. J., Logan, J., Wong, C., Gifford, A. J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00225-8 · Cited by 185
Self-citationWang, G., Volkow, N. D., HITZEMANN, R. J., Wong, C., ANGRIST, B. M., Burr, G., Pascani, K., Pappas, N. R., Lu, A., Cooper, T. B., et al. (2009) · European Addiction Research · doi:10.1159/000259147 · Cited by 70
Self-citationPeck, J. A., SHOPTAW, S. J., Rotheram-Fuller, E. J., Reback, C. J., & Bierman, B. (2005) · Journal of Addictive Diseases · doi:10.1300/j069v24n03_10 · Cited by 44
Sexual Side Effects Associated With Conventional and Atypical Antipsychotics
Compton, M. T., Miller, A. H., Miller, A. A. H., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4256 · Cited by 42
HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study
WOODY, G. E., Gallop, R., Luborsky, L. B., BLAINE, J. D., Frank, A. F., Salloum, I. M., Gastfriend, D. R., & Crits-Christoph, P. F. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200305010-00012 · Cited by 30
Käll, K. I., & Nilsonne, Å. (1995) · AIDS Care · doi:10.1080/09540129550126696 · Cited by 29
Pharmacology of α-Adrenoceptors in Male Sexual Function
Rampin, O. (1999) · European Urology · doi:10.1159/000052329 · Cited by 20
Flagged first, then by citations
Research works printed but not linked: 3
- Centers for Disease Control and Prevention, 2003, Morb Mortal Wkly Rep, 52, 634
- Molitor F, 1998, West J Med, 168, 93
- Compton MT, 2001, Psychopharmacol Bull, 35, 89
Cited by
Sorted by citations
A review of the clinical pharmacology of methamphetamine
Cruickshank, C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 802
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.003 · Cited by 663
Pain and suicidality: Insights from reward and addiction neuroscience
Elman, I., Borsook, D., & Volkow, N. D. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.003 · Cited by 226
Self-citationJohnson, M. W., & Bruner, N. R. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.032 · Cited by 209
Development of the treatment outcomes profile
Marsden, J., Farrell, M., Bradbury, C., Dale‐Perera, A., Eastwood, B., Roxburgh, M., & Taylor, S. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02284.x · Cited by 194
Metadata
- Authors
- Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Jayne, M., & Wong, C.
- Affiliations
- National Institute on Drug Abuse (US)
- Venue
- American Journal of Psychiatry
- Published
- 2007-01
- Volume
- 164
- Issue
- 1
- Pages
- 157-160
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2158876851
- Cited by
- 151
- References
- 16
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 1 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 12 · 2017: 7 · 2016: 13 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- HIV transmission, sexual desire, stimulant abuse, cocaine, methylphenidate, methamphetamine, sexual risk behavior, HIV risk factors
- MeSH terms
- Administration, Oral, Adult, Central Nervous System Stimulants, Dose-Response Relationship, Drug, Female, Humans, Injections, Intravenous, Libido, Male, Methamphetamine, Methylphenidate, Placebos, Risk-Taking, Sexual Behavior, HIV Infections, Comorbidity, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
